Rectal cancer most commonly spreads to the liver and lungs, with about 70% of metastatic cases involving the liver and up to 47% involving the thorax (chest area). Beyond these two primary sites, it can also reach the bones, brain, peritoneum (the lining of the abdominal cavity), and nearby pelvic organs. The pattern of spread depends on both the anatomy of the rectum’s blood supply and how advanced the cancer has become.
The Liver: Most Common Distant Site
The liver is the single most frequent destination for rectal cancer cells that break free from the original tumor. Nearly 50% of all colorectal cancer patients will develop liver metastases at some point during their disease, and roughly 30% of those already have liver involvement at the time of their initial diagnosis. This happens because blood from the rectum drains through the portal venous system, which flows directly to the liver before reaching the rest of the body. Cancer cells riding in the bloodstream essentially get filtered through the liver first, giving them an opportunity to lodge there and grow.
Liver metastases can cause nausea, jaundice (yellowing of the skin and eyes), and abdominal swelling. Many people, however, have no symptoms at all in the early stages of liver spread, which is why imaging scans are a routine part of rectal cancer staging and follow-up.
The Lungs: Especially Common in Rectal Cancer
Lung metastases are significantly more common in rectal cancer than in colon cancer. Rectal tumors spread to the thorax at roughly 2.4 times the rate of colon tumors. One large Chinese study of 404 rectal cancer patients found that the lungs were actually the most common metastatic site, with an incidence of 11.4%, roughly 1.5 times that of liver metastasis in that cohort.
The reason for this lung preference comes down to anatomy. The lower rectum drains partly through veins that bypass the portal system entirely and feed into the body’s general circulation, sending blood directly to the lungs. This gives rectal cancer cells a more direct route to lung tissue than colon cancer cells typically have. Symptoms of lung metastases include shortness of breath, chest pain, and a persistent cough, though small deposits often produce no symptoms and are detected only on CT scans.
Bone and Brain Metastases
Bone is the third most common distant site for rectal cancer, appearing in about 12% of patients with metastatic disease. This is notably higher than in colon cancer, where peritoneal spread takes that third spot instead. Bone metastases tend to cause deep, aching pain that worsens over time, and they can weaken the affected bone enough to cause fractures.
Brain and nervous system involvement occurs in roughly 8% of metastatic rectal cancer cases, again at a higher rate than colon cancer (about 5%). Rectal tumors are 1.5 times more likely to reach the nervous system compared to colon tumors. Symptoms depend on where the deposits land but can include headaches, vision changes, weakness on one side of the body, or difficulty with balance and coordination.
Peritoneal Spread
Interestingly, rectal cancer is far less likely to spread to the peritoneum than colon cancer is. Rectal tumors reach the peritoneum at only about one-third the rate of colon tumors. Still, it does happen. Studies report that 2% to 19% of patients develop peritoneal involvement after surgery intended to be curative, and autopsy studies find peritoneal deposits in up to 40% of people who die from colorectal cancer.
Peritoneal spread causes vague symptoms that are easy to miss early on: general abdominal discomfort, nausea, weight loss, and fatigue. As it progresses, tumor growth on intestinal surfaces and fluid buildup can lead to bowel obstruction and significant fluid accumulation in the abdomen. Historically, this type of spread carried a very poor prognosis, with median survival around 5 to 7 months. More modern treatment approaches have extended that considerably, with some studies reporting median survival of 23 months with current chemotherapy regimens and even longer with specialized surgical techniques.
Local Spread to Nearby Pelvic Organs
Before cancer reaches distant organs, it can grow directly into structures that sit right next to the rectum in the pelvis. In women, the uterus and vagina are common sites of direct invasion. In men, the prostate and seminal vesicles are at risk. The bladder, which sits in front of the rectum in both sexes, is another frequent target. Tumors that penetrate through the rectal wall and reach these adjacent organs are classified as T4, the most advanced local stage.
The rectum also sits against the sacrum (the triangular bone at the base of the spine), and advanced tumors can invade the pelvic sidewall or sacral nerves, causing pain that radiates into the legs or buttocks.
How Rectal Cancer Spreads: The Key Pathways
Rectal cancer uses two main routes to travel beyond the original tumor. The first is the bloodstream. Vein involvement occurs in about 40% of patients, and veins act as what researchers describe as a vascular “anatomical highway,” giving tumor cells rapid, direct access to distant organs. This is the primary route to the liver, lungs, bones, and brain.
The second route is the lymphatic system. Cancer cells travel through lymphatic vessels into nearby lymph nodes before potentially reaching more distant node groups. The first nodes affected are typically those within the mesorectum, the fatty tissue that surrounds the rectum. From there, spread moves outward to nodes along the major blood vessels: the superior rectal, inferior mesenteric, and internal iliac nodes. Nodes along the pelvic sidewall, including the obturator nodes, are a primary site of spread for tumors in the lower rectum. External iliac and common iliac nodes are less commonly involved and, when affected, are considered distant metastatic disease rather than regional spread.
One important distinction: lymph node involvement indicates regional spread but does not itself cause distant metastases. Research has shown that the direct vascular pathway to distant organs operates independently of lymph node spread, and the historical emphasis on lymph nodes as a driver of metastasis has been somewhat overestimated.
How Spread Is Detected
MRI is the most accurate tool for assessing how far the tumor has grown locally, including whether it has reached nearby organs, the pelvic sidewall, or regional lymph nodes. A pelvic MRI with a wide field of view can evaluate lymph node chains from the lower spine down to the anal sphincter. CT scans of the chest, abdomen, and pelvis are the standard method for finding distant metastases in the liver, lungs, and other organs. PET scans, which detect areas of high metabolic activity, are sometimes combined with CT or MRI to improve accuracy, particularly for detecting recurrence after treatment.
Survival With Metastatic Rectal Cancer
When rectal cancer has spread to distant sites, the five-year relative survival rate is 16.2%, according to the most recent data from the National Cancer Institute’s SEER program. About 23% of colorectal cancer cases are already at this distant stage at the time of diagnosis. These numbers represent averages across all patients and all metastatic sites. Individual outcomes vary widely depending on where the cancer has spread, how many organs are involved, and how well it responds to treatment. Isolated liver or lung metastases, for example, can sometimes be surgically removed, which substantially improves the outlook compared to widespread multi-organ involvement.